Moderna shares rose 9% on Wednesday after it settled a long-running legal battle over the technology that made its COVID-19 vaccine possible, removing an overhang and allowing it to focus on its pipeline.
Source :- Markets-Economic Times Read More
US Stocks: Moderna rises on $2.25 billion settlement, clearing COVID vaccine patent dispute overhang
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
